![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
(MM) | NASDAQ:IDIX | NASDAQ | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.50 | 0.00 | 01:00:00 |
Delaware | 45-0478605 | |
(State or other jurisdiction of
incorporation or organization) |
(IRS Employer
Identification Number) |
Large accelerated filer o | Accelerated filer þ | Non-accelerated filer o | Smaller reporting company o | |||
(Do not check if a smaller reporting company) |
Proposed maximum | ||||||||
Title of each class of securities | aggregate | Amount of | ||||||
to be registered (1) | offering price (2) | registration fee (2) | ||||||
Common Stock, $0.001 par value
per share
|
$9,826,883.55 | $1,141 | ||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EX-5.1 | ||||||||
EX-23.2 |
IDENIX PHARMACEUTICALS, INC.
|
||||
By: | /s/ Ronald C. Renaud, Jr. | |||
Name: | Ronald C. Renaud, Jr. | |||
Title: | President and Chief Executive Officer | |||
Signature | Title | Date | ||
/s/ Ronald C. Renaud, Jr.
|
President and Chief
Executive Officer and
Director
(Principal Executive Officer) |
April 8, 2011 | ||
|
||||
/s/ Daniella Beckman
|
Interim Chief Financial
Officer and Treasurer
(Principal Financial and Accounting Officer) |
April 8, 2011 | ||
|
||||
*
|
Director | April 8, 2011 | ||
Charles Cramb
|
||||
|
||||
*
|
Director | April 8, 2011 | ||
Wayne Hockmeyer
|
||||
|
||||
*
|
Director | April 8, 2011 | ||
Thomas Hodgson
|
||||
|
||||
|
Director | |||
Tamar Howson
|
||||
|
||||
*
|
Director | April 8, 2011 | ||
Robert Pelzer
|
||||
|
||||
*
|
Director | April 8, 2011 | ||
Denise Pollard-Knight
|
||||
|
||||
|
Director | |||
Anthony Rosenberg
|
* By: | /s/ Maria Stahl | ||
Name: | Maria Stahl | ||
Title: | Attorney-in-Fact |
Exhibit | ||||||||||||
No. | Description | Incorporated by Reference to | ||||||||||
Original | ||||||||||||
Filed | SEC Filing | Exhibit | ||||||||||
Herewith | Form | Date | Number | |||||||||
5.1 |
Opinion of Wilmer Cutler
Pickering Hale and Dorr LLP
|
X | ||||||||||
23.1 |
Consent of Wilmer Cutler
Pickering Hale and Dorr LLP
(included in Exhibit 5.1)
|
X | ||||||||||
23.2 |
Consent of Pricewaterhouse
Coopers LLP, an Independent
Registered Public
Accounting Firm
|
X | ||||||||||
24.1 |
Powers of Attorney
|
S-3 File No. 333-153471 | 09/12/2008 | 24.1 |
1 Year (MM) Chart |
1 Month (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions